<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">LUP</journal-id>
<journal-id journal-id-type="hwp">splup</journal-id>
<journal-id journal-id-type="nlm-ta">Lupus</journal-id>
<journal-title>Lupus</journal-title>
<issn pub-type="ppub">0961-2033</issn>
<issn pub-type="epub">1477-0962</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0961203311433138</article-id>
<article-id pub-id-type="publisher-id">10.1177_0961203311433138</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Familial SLE: sustained drug-free remission in a mother successfully treated for anal cancer, but development of SLE in a 16-year old daughter</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Catania</surname><given-names>G</given-names></name>
<xref ref-type="corresp" rid="corresp1-0961203311433138"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Rossi</surname><given-names>E</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Marmont</surname><given-names>A</given-names></name>
</contrib>
</contrib-group>
<aff id="aff1-0961203311433138">Ospedale San Martino – Ematologia, Genova, Italy</aff>
<author-notes>
<corresp id="corresp1-0961203311433138">Gioacchino Catania, Ospedale San Martino – Ematologia, Largo R Benzi 10, Genova 16133, Italy Email: <email>danycatania@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>21</volume>
<issue>6</issue>
<fpage>672</fpage>
<lpage>674</lpage>
<history>
<date date-type="received"><day>1</day><month>8</month><year>2011</year></date>
<date date-type="accepted"><day>10</day><month>11</month><year>2011</year></date>
</history>
<permissions>
<copyright-statement>© The Author(s), 2012. Reprints and permissions: http://www.sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>The immunopathogenesis of systemic lupus erythematosus has been thoroughly investigated recently, and genome-wide association studies have identified genes statistically associated with lupus. However, the progression to overt disease is dependent on the activation of environmental factors (‘triggers’), among which oestrogen stimulation is prominent. Here we report the case of a mother with long-standing SLE entering into long term drug-free remission following intensive, menopause-inducing chemoradiotherapy for cancer, and the opposite case of her daughter, who developed SLE following the initiation of her menstrual cycle.</p>
</abstract>
<kwd-group>
<kwd>Familial lupus</kwd>
<kwd>genetic factors</kwd>
<kwd>hormonal factors</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0961203311433138" sec-type="intro"><title>Introduction</title>
<p>The development of SLE is generally considered as a consequence of the interaction of many factors, among which genetic, hormonal and environmental ones predominate.<sup><xref ref-type="bibr" rid="bibr1-0961203311433138">1</xref></sup> In mice three loci, designated Sle 1, Sle 2 and Sle 3, have been shown to contain genes that mediate the loss of immunologic tolerance.<sup><xref ref-type="bibr" rid="bibr2-0961203311433138">2</xref></sup> Clinical studies have shown that lupus familiality was greater in 125 affected sib pairs than in 37 affected parent–offspring pairs.<sup><xref ref-type="bibr" rid="bibr3-0961203311433138">3</xref></sup> Well known further studies have also shown that concordance for the disease was significantly higher in monozygotic than in dizygotic twins.<sup><xref ref-type="bibr" rid="bibr4-0961203311433138">4</xref></sup> Familial aggregations have been studied extensively,<sup><xref ref-type="bibr" rid="bibr5-0961203311433138">5</xref></sup> and a strong clustering in families has been ascertained.<sup><xref ref-type="bibr" rid="bibr6-0961203311433138">6</xref></sup></p>
<p>Alleles of HLA-DRB1 and STAT-4 are considered established susceptibility genes. Further studies have indicated susceptibility variants in IT6AM, PXK, KIAA1542,<sup><xref ref-type="bibr" rid="bibr7-0961203311433138">7</xref></sup> and an association of SLE with C8orf13-BLK and IT6AM-ITGAX has been identified recently.<sup><xref ref-type="bibr" rid="bibr8-0961203311433138">8</xref></sup> An informative table indicating the significant causative role of each of these genetic variants has been published recently by Crow.<sup><xref ref-type="bibr" rid="bibr9-0961203311433138">9</xref></sup></p>
<p>Among the non-genetic factors, the promoting effect of female sex hormones is well established, and further studies have highlighted the importance of gender steroids in regulating (and enhancing, in the case of female hormones) various functions of the immune system.<sup><xref ref-type="bibr" rid="bibr10-0961203311433138">10</xref>,<xref ref-type="bibr" rid="bibr11-0961203311433138">11</xref></sup> Two hormonal sets are known to influence the immune system. Prolactin exerts its effects on B cells by rescuing autoreactive ones targeted for apoptosis. The way by which estradiol can stimulate the immune response has been reviewed recently.<sup><xref ref-type="bibr" rid="bibr12-0961203311433138">12</xref></sup> Peripheral lymphoid cells from patients with SLE have abnormal responses to oestrogen stimulation.</p>
<p>Here we present an observational study of SLE occurring in a mother and her only daughter, with clinical and humoral activity dependent of their individual hormonal situation.</p></sec>
<sec id="sec2-0961203311433138" sec-type="cases"><title>Case reports</title>
<p>The mother, 55 years old at the time of writing, was diagnosed with SLE at the age of 30 because of arthralgias, occasional episodes of fever, malar erythema and strong antinuclear activity (ANA 1:160 homogeneous, anti-ds DNA [Crithidia] 1:40). She was treated with low-dose corticosteroids and azathioprine, the latter having been later discontinued (as an added precaution) because of pregnancy. At the age of 39 years she gave birth to an apparently healthy female infant by means of caesarean section.</p>
<p>Seven years later she developed anal carcinoma, which was treated successfully with surgical excision and radiochemotherapy. Total cessation of menstrual cycles occurred. A clinical remission of SLE followed, but three years later she developed arthralgias in both hands, and was treated with low-dose corticosteroids for two years. Following a complete clinical remission steroids were discontinued, and she has been entirely drug-free for the last four years. Anti-ds DNA antibodies have been consistently negative, but ANAs persist with a titre of 1:160 and the usual homogeneous pattern.</p>
<p>The daughter, 16 years old at the time of writing, had her first menstruation at 13 years. In August, 2010 she presented with diffuse arthralgias. In October she was found to be leukopenic (WBC 2.3 × 109/L) and neutropenic (&lt;1.0 × 109/L). ANA (1:160 homo), anti-ds DNA antibodies (1:40 Crithidia) present with the concomitance of anti-SSA (Ro) antibody. She had an urticarioid rash following hydroxychloroquine, which was discontinued. In November 2010 her hands became swollen and painful, and she developed a butterfly facial erythema. There was a generalized, tender lymph-node enlargement. No evidence of kidney involvement was found. High titre anti-ds DNA and ANAs were present, and C3 and C4 were markedly reduced. At present, the patient is on corticosteroids and azathioprine and is in full clinical remission. Anti-ds DNA antibodies are no longer present, but the ANA positivity persists.</p>
<p>The hormonal results of both patients are reported in <xref ref-type="table" rid="table1-0961203311433138">Table 1</xref>.
<table-wrap id="table1-0961203311433138" position="float"><label>Table 1</label><caption><p>Hormonal status of mother and daughter</p></caption>
<graphic alternate-form-of="table1-0961203311433138" xlink:href="10.1177_0961203311433138-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Hormonal status</th>
<th>Mother<xref ref-type="table-fn" rid="table-fn1-0961203311433138">*</xref></th>
<th>Daughter<xref ref-type="table-fn" rid="table-fn2-0961203311433138">**</xref></th></tr></thead>
<tbody align="left">
<tr>
<td>FSH (IU/L)</td>
<td>65.1</td>
<td>5.27</td></tr>
<tr>
<td>LH (IU/L)</td>
<td>24.2</td>
<td>3.87</td></tr>
<tr>
<td>Estradiol (ng/L)</td>
<td>20</td>
<td>110</td></tr>
<tr>
<td>Progesterone (µg/L)</td>
<td>&lt;0.20</td>
<td>&lt;0.20</td></tr>
<tr>
<td>PRL (µg/L)</td>
<td>3.03</td>
<td>5.52</td></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0961203311433138"><label>*</label><p>Menopause.</p></fn>
<fn id="table-fn2-0961203311433138"><label>**</label><p>Follicular phase.</p></fn></table-wrap-foot>
</table-wrap></p></sec>
<sec id="sec3-0961203311433138" sec-type="discussion"><title>Discussion</title>
<p>The development of SLE is most generally considered as the consequence of the interaction between genetic factors and a variety of triggers,<sup><xref ref-type="bibr" rid="bibr1-0961203311433138">1</xref>,<xref ref-type="bibr" rid="bibr9-0961203311433138">9</xref></sup> among which the promoting effects of oestrogens and additional hormonal factors are well estabilished.<sup><xref ref-type="bibr" rid="bibr10-0961203311433138">10</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr12-0961203311433138">12</xref></sup> The two patients, mother and daughter, reported here have a common lupus-prone genome.<sup><xref ref-type="bibr" rid="bibr4-0961203311433138">4</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr8-0961203311433138">8</xref></sup> Whole genome sequencing of these individual patients was not performed, but the demonstration that mother and offspring carry established susceptibility alleles such as DRB1*03 and DQB1*02 are a robust indication of the genetic component of this familial disease.</p>
<p>However, the combination of iatrogenic menopause and additional powerful radiochemotherapy, exerting oncolytic, immunosuppressive and hormone-suppressing activity, completely suppressed the effects of extrinsic, non-genetic factors in the mother, thus ensuring a complete, drug-free, long-term remission. The persistence of low-grade ANAs (but not of anti-ds DNA antibodies) may be related to the well-known persistence of long-lived plasma cells,<sup><xref ref-type="bibr" rid="bibr13-0961203311433138">13</xref></sup> which have been shown to be able to survive for long, even very long, periods in appropriate survival niches.<sup><xref ref-type="bibr" rid="bibr14-0961203311433138">14</xref></sup> They are thus considered as an independent cellular component of the immunologic memory of the B lineage.<sup><xref ref-type="bibr" rid="bibr15-0961203311433138">15</xref></sup></p>
<p>In the daughter, contrariwise, the previously silent genome was triggered into clinical activity by the physiological incretion of female gender hormones. We believe that this is a typical clinical demonstration of the interaction between genetic and hormonal factors in the etiopathogenesis of SLE.</p>
<p>The response to carefully graduated corticotherapy in the daughter has been optimal, the mother is totally drug free and both patients are in excellent condition and leading normal lives.</p></sec>
</body>
<back>
<sec id="sec4-0961203311433138"><title>Funding</title>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></sec>
<sec id="sec5-0961203311433138"><title>Conflict of interest statement</title>
<p>None declared.</p></sec>
<ref-list>
<title>References</title>
<ref id="bibr1-0961203311433138"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crow</surname><given-names>MK</given-names></name></person-group>. <article-title>Developments in the clinical understanding of lupus</article-title>. <source>Arthritis Res Ther</source> <year>2009</year>; <volume>11</volume>: <fpage>245</fpage>–<lpage>256</lpage>.</citation></ref>
<ref id="bibr2-0961203311433138"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morel</surname><given-names>L</given-names></name><name><surname>Croker</surname><given-names>BP</given-names></name><name><surname>Blenman</surname><given-names>KR</given-names></name><etal/></person-group>. <article-title>Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains</article-title>. <source>Proc Natl Acad Sci USA</source> <year>2000</year>; <volume>97</volume>: <fpage>6870</fpage>–<lpage>6875</lpage>.</citation></ref>
<ref id="bibr3-0961203311433138"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsao</surname><given-names>BP</given-names></name><name><surname>Grossman</surname><given-names>JM</given-names></name><name><surname>Riemekasten</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Familiality and co-occurrence of clinical features of systemic lupus erythematosus</article-title>. <source>Arthritis Rheum</source> <year>2002</year>; <volume>46</volume>: <fpage>2678</fpage>–<lpage>2685</lpage>.</citation></ref>
<ref id="bibr4-0961203311433138"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Block</surname><given-names>SR</given-names></name></person-group>. <article-title>A brief history of twins</article-title>. <source>Lupus</source> <year>2006</year>; <volume>15</volume>: <fpage>61</fpage>–<lpage>64</lpage>.</citation></ref>
<ref id="bibr5-0961203311433138"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alarcón-Segovia</surname><given-names>D</given-names></name><name><surname>Alarcón-Riquelme</surname><given-names>ME</given-names></name><name><surname>Cardiel</surname><given-names>MH</given-names></name></person-group>. <article-title>Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort</article-title>. <source>Arthritis Rheum</source> <year>2005</year>; <volume>52</volume>: <fpage>1138</fpage>–<lpage>1147</lpage>.</citation></ref>
<ref id="bibr6-0961203311433138"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harley</surname><given-names>IT</given-names></name><name><surname>Kaufman</surname><given-names>KM</given-names></name><name><surname>Langefeld</surname><given-names>CD</given-names></name><name><surname>Harley</surname><given-names>JB</given-names></name><name><surname>Kelly</surname><given-names>JA</given-names></name></person-group>. <article-title>Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies</article-title>. <source>Nat Rev Genet</source> <year>2009</year>; <volume>10</volume>: <fpage>285</fpage>–<lpage>290</lpage>.</citation></ref>
<ref id="bibr7-0961203311433138"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harley</surname><given-names>JB</given-names></name><name><surname>Alarcón-Riquelme</surname><given-names>ME</given-names></name><name><surname>Criswell</surname><given-names>LA</given-names></name><etal/></person-group>. <article-title>Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci</article-title>. <source>Nat Genet</source> <year>2008</year>; <volume>40</volume>: <fpage>204</fpage>–<lpage>210</lpage>.</citation></ref>
<ref id="bibr8-0961203311433138"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hom</surname><given-names>G</given-names></name><name><surname>Graham</surname><given-names>RR</given-names></name><name><surname>Modrek</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX</article-title>. <source>N Engl J Med</source> <year>2008</year>; <volume>358</volume>: <fpage>900</fpage>–<lpage>909</lpage>.</citation></ref>
<ref id="bibr9-0961203311433138"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crow</surname><given-names>MK</given-names></name></person-group>. <article-title>Collaboration, genetic associations, and lupus erythematosus</article-title>. <source>N Engl J Med</source> <year>2008</year>; <volume>358</volume>: <fpage>956</fpage>–<lpage>961</lpage>.</citation></ref>
<ref id="bibr10-0961203311433138"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cutolo</surname><given-names>M</given-names></name><name><surname>Sulli</surname><given-names>A</given-names></name><name><surname>Capellino</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity</article-title>. <source>Lupus</source> <year>2004</year>; <volume>13</volume>: <fpage>635</fpage>–<lpage>638</lpage>.</citation></ref>
<ref id="bibr11-0961203311433138"><label>11</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Rider</surname><given-names>V</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Abdou</surname><given-names>NL</given-names></name></person-group>. <article-title>Hormonal influences in the expression of systemic lupus erythematosus</article-title>. In: <person-group person-group-type="editor"><name><surname>Tsokos</surname><given-names>GC</given-names></name><name><surname>Gordon</surname><given-names>C</given-names></name><name><surname>Smolen</surname><given-names>JG</given-names></name></person-group> (eds). <source>Systemic lupus erythematosus</source>. <publisher-loc>Philadelphia</publisher-loc>: <publisher-name>Mosby-Elsevier</publisher-name>, <year>2007</year>; <fpage>87</fpage>–<lpage>94</lpage>.</citation></ref>
<ref id="bibr12-0961203311433138"><label>12</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>SE</given-names></name></person-group>. <article-title>The importance of sex hormones in systemic lupus erythematosus</article-title>. In: <person-group person-group-type="editor"><name><surname>Wallace</surname><given-names>DJ</given-names></name><name><surname>Hah</surname><given-names>BH</given-names></name></person-group> (eds). <source>Dubois’s lupus erythematosus</source>. <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>, <year>2007</year>; <fpage>273</fpage>–<lpage>285</lpage>.</citation></ref>
<ref id="bibr13-0961203311433138"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoyer</surname><given-names>BF</given-names></name><name><surname>Moser</surname><given-names>K</given-names></name><name><surname>Hauser</surname><given-names>AE</given-names></name></person-group>. <article-title>Long-lived plasma cells and their contribution to autoimmunity</article-title>. <source>Ann NY Acad Sci<italic>. Philadelphia, Baltimore, New York, London,</italic></source> <year>2005</year>; <volume>1050</volume>: <fpage>124</fpage>–<lpage>133</lpage>.</citation></ref>
<ref id="bibr14-0961203311433138"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radbruch</surname><given-names>A</given-names></name><name><surname>Muehlinghaus</surname><given-names>G</given-names></name><name><surname>Luger</surname><given-names>EO</given-names></name><etal/></person-group>. <article-title>Competence and competition: the challenge of becoming a long-lived plasma cell</article-title>. <source>Nat Rev Immunol</source> <year>2006</year>; <volume>6</volume>: <fpage>741</fpage>–<lpage>750</lpage>.</citation></ref>
<ref id="bibr15-0961203311433138"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>N</given-names></name><name><surname>Stohl</surname><given-names>W</given-names></name></person-group>. <article-title>Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present and future</article-title>. <source>Autoimmunity</source> <year>2010</year>; <volume>43</volume>: <fpage>84</fpage>–<lpage>97</lpage>.</citation></ref>
</ref-list>
</back>
</article>